{"public_id":"cl_ffa2e60553d83b2b25346601bae42a20","status":"active","superseded_by_public_id":null,"corpus_id":43588752,"text":"High HIF1a expression shows 87.1% sensitivity and 55.6% specificity for distinguishing short survival from long survival.","confidence":0.95,"paper":{"corpus_id":43588752,"title":"High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF.","url":"https://sah.borca.ai/papers/43588752"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.95,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_1640ba542c934619d3762ff94bf72066","name":"short survival","description":"Survival lasting less than 6 months, used as a prognostic category.","types":["prognostic category"],"url":"https://sah.borca.ai/concepts/co_1640ba542c934619d3762ff94bf72066"},{"public_id":"co_52551f088f0ba647284cb230b9c5c380","name":"HIF1a mRNA expression","description":"The measured level of HIF1a transcript expression in pancreatic tumor tissue.","types":["molecular marker"],"url":"https://sah.borca.ai/concepts/co_52551f088f0ba647284cb230b9c5c380"},{"public_id":"co_d0981d1180d99d68e37baa8ca691210d","name":"long survival","description":"Survival lasting 6 to 60 months, used as a prognostic category.","types":["prognostic category"],"url":"https://sah.borca.ai/concepts/co_d0981d1180d99d68e37baa8ca691210d"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_ffa2e60553d83b2b25346601bae42a20"}